BDBM349492 US10206931, Example 300::methyl-2-oxo-1,3,4,5-

SMILES: CN\C=C(/C=N)c1cc(F)c(Nc2cccc3NC(=O)C[C@@H](C)Nc23)cc1C#N

InChI Key: InChIKey=WOEYUFUBROFUNE-FZLAJWJKSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 349492   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
BRD4 BD1 (aa 42-168) (Homo sapiens (Human))	BDBM349492 (US10206931, Example 300 | methyl-2-oxo-1,3,4,5-) Show SMILES CN\C=C(/C=N)c1cc(F)c(Nc2cccc3NC(=O)C[C@@H](C)Nc23)cc1C#N |r| Show InChI InChI=1S/C21H21FN6O/c1-12-6-20(29)28-18-5-3-4-17(21(18)26-12)27-19-7-13(9-23)15(8-16(19)22)14(10-24)11-25-2/h3-5,7-8,10-12,24-27H,6H2,1-2H3,(H,28,29)/b14-11+,24-10?/t12-/m1/s1	PDB GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	8.19E+3	n/a	n/a	n/a	n/a	n/a	n/a
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent					Assay Description His/Flag epitope tagged BRD4 BD142-168 was cloned, expressed, and purified to. BRD4 binding and inhibition was assessed by monitoring the engagement ...				US Patent US10206931 (2019) BindingDB Entry DOI: 10.7270/Q2GM89FR
					More data for this Ligand-Target Pair
CREB-binding protein (Homo sapiens (Human))	BDBM349492 (US10206931, Example 300 | methyl-2-oxo-1,3,4,5-) Show SMILES CN\C=C(/C=N)c1cc(F)c(Nc2cccc3NC(=O)C[C@@H](C)Nc23)cc1C#N |r| Show InChI InChI=1S/C21H21FN6O/c1-12-6-20(29)28-18-5-3-4-17(21(18)26-12)27-19-7-13(9-23)15(8-16(19)22)14(10-24)11-25-2/h3-5,7-8,10-12,24-27H,6H2,1-2H3,(H,28,29)/b14-11+,24-10?/t12-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	12	n/a	n/a	n/a	n/a	n/a	n/a
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent					Assay Description His/Flag epitope tagged CBP was cloned, expressed, and purified to homogeneity. CBP binding and inhibition was assessed by monitoring the engagement ...				US Patent US10206931 (2019) BindingDB Entry DOI: 10.7270/Q2GM89FR
					More data for this Ligand-Target Pair